RHOADS ANN D

Insider

Director

Trades at: GMED· QDEL· RPTX· ITOS· QDEL· EVOK

30D 90D 1Y

Net shares · 365d

-19.2K

750 buy · 20.0K sell

Net value · 365d

-$1.4M

$21.2K in · $1.4M out

Sentiment · 365d

Net selling

1% buying · 99% selling

Open-market trades · 365d

750 buy · 20.0K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

QDEL Buy·P
Dec 10, 25

Director

$21.2K

750 sh · $28.28

Own +5%
GMED Sell·S
Nov 10, 25

Director · 10b5-1

$818.0K

10.0K sh · $81.80 avg · 2 lots

Own -39%
GMED Sell·S
Sep 15, 25

Director · 10b5-1

$584.6K

10.0K sh · $58.46

Own -28%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Dec 10, 2025	QDEL	Director	Buy P	750	+5%	$28.28	$21.2K
Nov 10, 2025	GMED	Director	Sell S	10.0K2 lots	-39%	$81.80 avg	$818.0K
Sep 15, 2025	GMED	Director	Sell S	10.0K	-28%	$58.46	$584.6K

Buy Sell Non-market (grant · exercise · gift)

About RHOADS ANN D

This profile aggregates every SEC Form 4 insider transaction reported by RHOADS ANN D across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.